Anthony P. DeFeo

914 total citations
11 papers, 541 citations indexed

About

Anthony P. DeFeo is a scholar working on Molecular Biology, Genetics and Oncology. According to data from OpenAlex, Anthony P. DeFeo has authored 11 papers receiving a total of 541 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 4 papers in Genetics and 2 papers in Oncology. Recurrent topics in Anthony P. DeFeo's work include CRISPR and Genetic Engineering (8 papers), RNA Interference and Gene Delivery (4 papers) and Virus-based gene therapy research (4 papers). Anthony P. DeFeo is often cited by papers focused on CRISPR and Genetic Engineering (8 papers), RNA Interference and Gene Delivery (4 papers) and Virus-based gene therapy research (4 papers). Anthony P. DeFeo collaborates with scholars based in United States, Germany and Italy. Anthony P. DeFeo's co-authors include Mark J. Osborn, Jakub Tolar, Bruce R. Blazar, Beau R. Webber, Amber McElroy, John E. Wagner, J. Keith Joung, Manfred Schmidt, Daniel F. Voytas and Richard Gabriel and has published in prestigious journals such as International Journal of Molecular Sciences, Molecular Therapy and Human Gene Therapy.

In The Last Decade

Anthony P. DeFeo

10 papers receiving 532 citations

Peers

Countries citing papers authored by Anthony P. DeFeo

Since Specialization

Citations

This map shows the geographic impact of Anthony P. DeFeo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anthony P. DeFeo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anthony P. DeFeo more than expected).

Fields of papers citing papers by Anthony P. DeFeo

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anthony P. DeFeo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anthony P. DeFeo. The network helps show where Anthony P. DeFeo may publish in the future.

Co-authorship network of co-authors of Anthony P. DeFeo

This figure shows the co-authorship network connecting the top 25 collaborators of Anthony P. DeFeo. A scholar is included among the top collaborators of Anthony P. DeFeo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anthony P. DeFeo. Anthony P. DeFeo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

11 of 11 papers shown

#	Work	Indexed citations
1	Clinical manufacture of CRISPR/Cas9-based cytokine-induced SH2 protein knock-out tumor-infiltrating lymphocytes for gastrointestinal cancers 2025 ·Cytotherapy ·Matthew J. Johnson, Darin Sumstad, Timothy D. Folsom, Nicholas J. Slipek, Anthony P. DeFeo, (unknown), Diane Kadidlo, Bharat Thyagarajan, Timothy K. Starr, Emil Lou, (unknown), Branden S. Moriarity, Beau R. Webber, David H. McKenna	0
2	Cas9-induced targeted integration of large DNA payloads in primary human T cells via homology-mediated end-joining DNA repair 2023 ·Nature Biomedical Engineering ·Beau R. Webber, Matthew J. Johnson, Joseph G. Skeate, Nicholas J. Slipek, Walker S. Lahr, Anthony P. DeFeo, Lauren J. Mills, Xiaohong Qiu, (unknown), Miechaleen D. Diers, (unknown), Tom Henley, (unknown), Timothy K. Starr, R. Scott McIvor, Branden S. Moriarity	12
3	Correction of Fanconi Anemia Mutations Using Digital Genome Engineering 2022 ·International Journal of Molecular Sciences ·(unknown), Mitchell G. Kluesner, (unknown), Walker S. Lahr, (unknown), (unknown), Anthony P. DeFeo, (unknown), Kanut Laoharawee, John E. Wagner, Margaret L. MacMillan, Gregory M. Vercellotti, Jakub Tolar, Mark J. Osborn, R. Scott McIvor, Beau R. Webber, Branden S. Moriarity	5
4	CRISPR/Cas9-Mediated Correction of the FANCD1 Gene in Primary Patient Cells 2017 ·International Journal of Molecular Sciences ·(unknown), Mark J. Osborn, Beau R. Webber, Anthony P. DeFeo, Amber McElroy, Chong Ae Kim, Jakub Tolar	22
5	CRISPR/Cas9 Targeted Gene Editing and Cellular Engineering in Fanconi Anemia 2016 ·Stem Cells and Development ·Mark J. Osborn, Cara-lin Lonetree, Beau R. Webber, Dharmeshkumar Patel, Samantha K. Dunmire, Anthony P. DeFeo, Amber McElroy, Margaret L. MacMillan, John E. Wagner, Bruce R. Blazar, Jakub Tolar	26
6	CRISPR/Cas9-based genetic correction for recessive dystrophic epidermolysis bullosa 2016 ·npj Regenerative Medicine ·Beau R. Webber, Mark J. Osborn, Amber McElroy, Kirk Twaroski, Cara-lin Lonetree, Anthony P. DeFeo, Lily Xia, Cindy Eide, Christopher J. Lees, Ron McElmurry, Megan Riddle, Chong Jai Kim, Dharmeshkumar Patel, Bruce R. Blazar, Jakub Tolar	80
7	Angiotensin receptor blockade mediated amelioration of mucopolysaccharidosis type I cardiac and craniofacial pathology 2016 ·Journal of Inherited Metabolic Disease ·Mark J. Osborn, Beau R. Webber, (unknown), Kyle Rudser, Anthony P. DeFeo, (unknown), Anna Petryk, Benedikt Hallgrímsson, Bruce R. Blazar, Jakub Tolar, Elizabeth Braunlin	10
8	Fanconi Anemia Gene Editing by the CRISPR/Cas9 System 2014 ·Human Gene Therapy ·Mark J. Osborn, Richard Gabriel, Beau R. Webber, Anthony P. DeFeo, Amber McElroy, Jordan Jarjour, Colby G. Starker, John E. Wagner, J. Keith Joung, Daniel F. Voytas, Christof von Kalle, Manfred Schmidt, Bruce R. Blazar, Jakub Tolar	91
9	TALEN-based Gene Correction for Epidermolysis Bullosa 2013 ·Molecular Therapy ·Mark J. Osborn, Colby G. Starker, Amber McElroy, Beau R. Webber, Megan Riddle, Lily Xia, Anthony P. DeFeo, Richard Gabriel, Manfred Schmidt, Christof von Kalle, Daniel F. Carlson, Morgan L. Maeder, J. Keith Joung, John E. Wagner, Daniel F. Voytas, Bruce R. Blazar, Jakub Tolar	203
10	Synthetic Zinc Finger Nuclease Design and Rapid Assembly 2011 ·Human Gene Therapy ·Mark J. Osborn, Anthony P. DeFeo, Bruce R. Blazar, Jakub Tolar	15
11	Minicircle DNA-based Gene Therapy Coupled With Immune Modulation Permits Long-term Expression of α-L-Iduronidase in Mice With Mucopolysaccharidosis Type I 2010 ·Molecular Therapy ·Mark J. Osborn, Ron McElmurry, Christopher J. Lees, Anthony P. DeFeo, (unknown), Mark A. Kay, Luigi Naldini, Gordon J. Freeman, Jakub Tolar, Bruce R. Blazar	77

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact